姜嫣嫣，女，分别于1990年和1999年获沈阳药科大学学士和硕士学位，2005年获复旦大学博士学位。主要从事肿瘤靶向递释系统的基础研究和高效、速效、长效制剂的研究开发。已发表论文10余篇，其中已在Biomaterials,PharmaceuticalResearch,BioconjugateChemistry等SCI期刊发表7篇论文,申请发明专利3项以及获各类科研奖四项。已完成和正在承担国家自然科学基金、上海市科委项目及参与国家973项目和国家重大新药创制项目。
1.Yan-YanJiang,ChenLiu,Ming-HuangHong,Sai-JieZhu,andYuan-YingPei.Tumorcelltargetingoftransferrin-PEG-TNF-aconjugateviaareceptor-mediateddeliverysystem:design,synthesis,andbiologicalevaluation.BioconjugateChemistry.2007,18:41-49.2.Yan-YanJiang,Guo-TaoTang,Ming-HuangHong,Sai-JieZhu,ChaoFang,BinShiandYuan-YingPei.Activetumor-targeteddeliveryofPEG-proteinviatransferrin-transferrin-receptorsystem.JournalofDrugTargeting.2007,15(10):672-683.3.SaijieZhu,MinghuangHong,GuotaoTang,LiliQian,JiayuanLin,YanyanJiang*,YuanyingPei.PartlyPEGylatedpolyamidoaminedendrimerfortumor-selectivetargetingofdoxorubicin:theeffectsofPEGylationdegreeanddrugconjugationstyle.Biomaterials,2010,31:1360-1371.4.SaijieZhu,MinghuangHong,LihongZhang,GuotaoTang,YanyanJiang*,YuanyingPei.PEGylatedPAMAMDendrimer-DoxorubicinConjugates:InvitroEvaluation,andInvivoTumorAccumulation.PharmaceuticalResearch,2010,27:161-174.5.Yan-YanJiang,Guo-TaoTang,Li-HongZhang,Shu-YiKong,Sai-JieZhu,Yuan-YingPei*.PEGylatedPAMAMdendrimersasapotentialdrugdeliverycarrier:invitroandinvivocomparativeevaluationofcovalentlyconjugateddrugandnon-covalentdruginclusioncomplex.Journalofdrugtargeting,2010,online. 